The role of Fusobacterium nucleatum as a promising prognostic biomarker for esophageal cancer was discussed by Yamamura et al., who found that higher amount of F. nucleatum in tumor tissue correlates with a poor prognosis and also activates CCL20, which promotes tumor progression [8]. Here, CCL20 is linked to neoplasm.